Suk-Hyung Kwon

Chief Executive Officer at NOVAREX CO.,LTD.

Net worth: 25 M $ as of 29/04/2024

69 year

Health Technology

Finance

Consumer Services

Suk-Hyung Kwon active positions

Companies	Position	Start	End
NOVAREX CO.,LTD.	Chief Executive Officer	21/03/2019	-
	Chairman	21/03/2019	-
	President	-	-
NOVAKMED	Chief Executive Officer	01/01/2017	-
Korea Health Supplements Association	Chairman	24/02/2016	-
STIC Investments, Inc. (South Korea) STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC Investments, Inc. (South Korea) is a private equity subsidiary of STIC Investments, Inc. founded in 1999 by Yong-Hwan Do and Byung-Won Choi. STIC Investments, Inc. (South Korea) is headquartered in Seoul, South Korea.	Private Equity Analyst	-	-

Companies	Position	Start	End
REXAHN PHARMACEUTICALS, INC.	Director/Board Member	28/02/2001	13/06/2005

Chung-Ang University

Doctorate Degree

International

Operational

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
NOVAREX CO.,LTD.	Health Technology

Private companies	4
Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.	Health Technology
STIC Investments, Inc. (South Korea) STIC Investments, Inc. (South Korea) Investment ManagersFinance STIC Investments, Inc. (South Korea) is a private equity subsidiary of STIC Investments, Inc. founded in 1999 by Yong-Hwan Do and Byung-Won Choi. STIC Investments, Inc. (South Korea) is headquartered in Seoul, South Korea.	Finance
Korea Health Supplements Association
NOVAKMED